How have MBI shares performed in 2024?

Med Biogene's stock was trading at C$0.05 on January 1st, 2024. Since then, MBI stock has increased by 0.0% and is now trading at C$0.05. View the best growth stocks for 2024 here .

When is Med Biogene's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 24th 2024. View our MBI earnings forecast .

How do I buy shares of Med Biogene?

Shares of MBI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

CVE:MBI

Med Biogene (MBI) Stock Price, News & Analysis

→ Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad)

Free MBI Stock Alerts

C$0.04

-0.01 (-18.18%)

(As of 10/3/2019)

Compare

Today's Range: C$0.05
▼
C$0.05
50-Day Range: C$0.05
▼
C$0.05
52-Week Range: C$0.02
▼
C$0.08

Volume: 2,000 shs
Average Volume: 29,135 shs
Market Capitalization: C$596,610.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Med Biogene alerts:

Ad Stansberry Research

Mysterious Gold Leverage Just Announced

World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.

Find out what it is and see how you can get in with just a few dollars.

About Med Biogene

Med BioGene Inc., a life science company, focuses on the development and commercialization of genomic-based clinical laboratory diagnostic tests for cancer. Its products include the GeneFx Lung, a gene expression-based test for early-stage non-small-cell lung cancer that assists in identifying patients for adjuvant chemotherapy. The company has a collaboration agreement with the University Health Network in Toronto. Med BioGene Inc. was founded in 2002 and is headquartered in Vancouver, Canada.

MBI Stock Price History

30 days | 90 days | 365 days | Advanced Chart

MBI Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive MBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Med Biogene and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/25/2024
Next Earnings (Estimated): 5/24/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: CVE
Sector: Medical
Industry: Diagnostics & Research
Sub-Industry: N/A
Current Symbol: CVE:MBI
CUSIP: N/A
CIK: N/A
Web: www.medbiogene.com
Phone: +1-604-7327332
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.95
Quick Ratio: 0.92

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: C$0.01 per share
Price / Cash Flow: 3.46
Book Value: C$0.00 per share
Price / Book: -45.00

Miscellaneous

Outstanding Shares: 13,258,000
Free Float: N/A
Market Cap: C$596,610.00
Optionable: Not Optionable
Beta: N/A

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Dr. Iain Weir-Jones Ph.D.
P.Eng., FGS, Chairman & CEO
Mr. Ibrahim Ghobrial
Chief Financial Officer

Key Competitors

View All Competitors

MBI Stock Analysis - Frequently Asked Questions

How have MBI shares performed in 2024?: Med Biogene's stock was trading at C$0.05 on January 1st, 2024. Since then, MBI stock has increased by 0.0% and is now trading at C$0.05.
View the best growth stocks for 2024 here.
When is Med Biogene's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Friday, May 24th 2024.
View our MBI earnings forecast.
How do I buy shares of Med Biogene?: Shares of MBI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:MBI) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial